LNTH | Lantheus Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	82.14 - 86.60
52 Week Range	50.20 - 126.89
Beta	0.22
Implied Volatility	42.77%
IV Rank	27.90%
Day's Volume	2,006,498
Average Volume	881,195
Shares Outstanding	69,526,800
Market Cap	6,010,591,860
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2015-06-25

Valuation
Profitability
Growth
Health
P/E Ratio	14.36
Forward P/E Ratio	16.51
EPS	6.02
1YR Price Target	102.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	834
Country	USA
Website	LNTH

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

LNTH's peers: AQST, DVAX, ELAN, NBIX, DCPH, IRWD, ALKS, AVDL, ANIP, RDY, COLL, PCRX, ALVOW, CTLT, AMPH, DERM, TGLS, VTRS, HLN

*Chart delayed

Analyzing fundamentals for LNTH we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is stunning wealthy, Growth is good and Health is very strong. For more detailed analysis please see LNTH Fundamentals page.

Watching at LNTH technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on LNTH Technicals page.